Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Bio-innova Co., Ltd

Home Clinical Trial Sponsors and OrganizationsBio-innova Co., Ltd

Bio-innova Co., Ltd

ACTIVE

Thailandbio-innova.comPrivate

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

108

86 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

108

100.0%

Trial Status Distribution

Active, not recruiting

1

0.9%

Completed

4

3.7%

Not yet recruiting

85

78.7%

Recruiting

1

0.9%

Unknown

17

15.7%

Clinical Trials

Trials sponsored by this organization (108)

A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Vortioxetine 20 mg Tablets relative to Brintellix (Vortioxetine tablets 20mg), in healthy Thai participants under fasting condition

Active, not recruiting

Aug 202630 participants

Sildenafil 100 mg Tablets Relative to Viagra 100 mg Tablets

Not yet recruiting

Feb 202536 participants

Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets Under Fed Condition

Not yet recruiting

Oct 202440 participants

Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule

Not yet recruiting

Sep 202428 participants

Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets

Not yet recruiting

Sep 202448 participants

Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets

Not yet recruiting

Sep 202446 participants

Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets Under Fasting Condition

Not yet recruiting

Aug 202430 participants

Dapagliflozin Tablet 10 mg Relative to Forxiga® Tablets 10 mg

Not yet recruiting

Jul 202430 participants

Page 1 of 14

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials108
Approvals
News

Back to Organizations